NanoString Technologies, Inc.
NanoString Technologies, Inc. (NSTG) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NSTG · as of Mar 31, 2024
Ownership Breakdown
7
Institutional Holders
▼ 86 vs Q4
$135,692
Total Inst. Value
▼ $28.14M vs Q4
48.12M
Shares Outstanding
freeFloat 81.90%
1.70M
13F Shares Held
▼ 36.08M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NSTG largest shareholders · institutional ownership
Q1 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC biological products, (no diagnostic substances) | 1.58M | 3.31% | 3.31% | $126.00M | May 10, 2024 | ▼ 551.8K |
CADENCE WEALTH MANAGEMENT LLC biological products, (no diagnostic substances) | 41.9K | 8.78% | 8.78% | $3.35M | May 10, 2024 | ▲ 22.9K |
EVOLUTION WEALTH ADVISORS, LLC biological products, (no diagnostic substances) | 28.0K | 5.87% | 5.87% | $2.24M | Apr 19, 2024 | — held |
XTX TOPCO LTD biological products, (no diagnostic substances) | 26.1K | 5.48% | 5.48% | $2.09M | May 13, 2024 | ▼ 40.7K |
GOLDMAN SACHS GROUP INC biological products, (no diagnostic substances) | 21.5K | 4.51% | 4.51% | $1.72M | May 15, 2024 | ▼ 770.3K |
BARCLAYS PLC biological products, (no diagnostic substances) | 2.0K | 0.42% | 0.42% | $159,000 | Mar 24, 2026 | ▼ 71.2K |
THOMPSON INVESTMENT MANAGEMENT, INC. biological products, (no diagnostic substances) | 1.6K | 0.34% | 0.34% | $128,000 | Apr 15, 2024 | — held |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 0 | 0.00% | 0.00% | $0 | May 15, 2024 | EXIT |
NORTHERN TRUST CORP biological products, (no diagnostic substances) | 0 | 0.00% | 0.00% | $0 | May 14, 2024 | EXIT |
JPMORGAN CHASE & CO biological products, (no diagnostic substances) | 0 | 0.00% | 0.00% | $0 | Dec 26, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2024 vs prior quarter
Q1 2024
1
Increased
+22.9K shares0
New Positions
first time holders4
Decreased
−1.43M shares43
Sold Out
fully exitedNet shares change (top 50)
1.41M
+22.9K / −1.43M
Net new holders
-46
0 new / 43 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NSTG insider trading · insider activity
Source: SEC Form 4
20
Buy transactions
16
Sell transactions
1.25
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
NanoString Technologies, Inc. (NSTG) is primarily owned by institutional investors, who hold approximately 3.5% of total shares outstanding. Company insiders own approximately 18.10%, while retail and public investors account for the remaining 78.37%.
The largest institutional shareholder of NanoString Technologies, Inc. is ACADIAN ASSET MANAGEMENT LLC, holding approximately 1.58 million shares — equal to 3.31% of outstanding shares — as of March 31, 2024.
A total of 7 institutional investors currently hold NSTG stock, with a combined institutional value of approximately $135,692 as of the most recent 13F filing period.
Frequently asked questions
NSTG ownershipNanoString Technologies, Inc. (NSTG) is primarily owned by institutional investors, who hold approximately 3.5% of shares. The largest shareholder is ACADIAN ASSET MANAGEMENT LLC with a 3.31% stake. Company insiders hold 18.10%. Data sourced from SEC Form 13F as of March 31, 2024.